Search research articles
Contact Us
Filters
Showing results (11-20 of 33) with videos related to
Page
of 4
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
March 26, 2013
Who benefits from adjuvant radiation therapy for gastric cancer? A meta-analysis
Nitin Ohri, Madhur K Garg, Santiago Aparo, et al.
Hepatology International
|
August 3, 2019
Association between neutrophil-lymphocyte ratio, socioeconomic status, and ethnic minority with treatment outcome in hepatocellular carcinoma
Yifei Zhang, N Patrik Brodin, Nitin Ohri, et al.
Journal of Gastrointestinal Cancer
|
November 3, 2019
The Neutrophil-to-Lymphocyte Ratio is a Prognostic Biomarker in An Ethnically Diverse Patient Population with Advanced Pancreatic Cancer
Michael Shusterman, Erin Jou, Andreas Kaubisch, et al.
Canadian Journal of Gastroenterology & Hepatology
|
December 12, 2018
Model for End-Stage Liver Disease and Sodium Velocity Predicts Overall Survival in Nonmetastatic Hepatocellular Carcinoma Patients
Justin Y Tang, Nitin Ohri, Rafi Kabarriti, et al.
Journal of Gastrointestinal Oncology
|
June 12, 2019
Centers with more therapeutic modalities are associated with improved outcomes for patients with hepatocellular carcinoma
Julie M Jiang, Nitin Ohri, Justin Tang, et al.
Clinical Colorectal Cancer
|
January 31, 2012
PTEN gene expression and mutations in the PIK3CA gene as predictors of clinical benefit to anti-epidermal growth factor receptor antibody therapy in patients with KRAS wild-type metastatic colorectal cancer
Arjun Sood, Danielle McClain, Radhashree Maitra, et al.
American Journal of Clinical Oncology
|
September 10, 2009
Phase II study of paclitaxel plus the protein kinase C inhibitor bryostatin-1 in advanced pancreatic carcinoma
Anthony P Lam, Joseph A Sparano, Vincent Vinciguerra, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
October 12, 2022
Induction Chemotherapy With FOLFIRINOX Followed by Chemoradiation With Gemcitabine in Patients With Borderline-Resectable Pancreatic Ductal Adenocarcinoma
Ana Acuna-Villaorduna, Viswanathan Shankar, Michael Wysota, et al.
Investigational New Drugs
|
January 2, 2007
Pharmacokinetic and safety study of weekly irinotecan and oral capecitabine in patients with advanced solid cancers
Sanjay Goel, Kavita Desai, Sirisha Karri, et al.
Investigational New Drugs
|
October 14, 2018
Survival outcome and prognostic model of patients with colorectal cancer on phase 1 trials
Audrey E Kam, Gopichand Pendurti, Umang H Shah, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 33) with videos related to
Sort By:
Page
of 4
International Journal of Radiation Oncology, Biology, Physics
|
March 26, 2013
Who benefits from adjuvant radiation therapy for gastric cancer? A meta-analysis
Nitin Ohri, Madhur K Garg, Santiago Aparo, et al.
Hepatology International
|
August 3, 2019
Association between neutrophil-lymphocyte ratio, socioeconomic status, and ethnic minority with treatment outcome in hepatocellular carcinoma
Yifei Zhang, N Patrik Brodin, Nitin Ohri, et al.
Journal of Gastrointestinal Cancer
|
November 3, 2019
The Neutrophil-to-Lymphocyte Ratio is a Prognostic Biomarker in An Ethnically Diverse Patient Population with Advanced Pancreatic Cancer
Michael Shusterman, Erin Jou, Andreas Kaubisch, et al.
Canadian Journal of Gastroenterology & Hepatology
|
December 12, 2018
Model for End-Stage Liver Disease and Sodium Velocity Predicts Overall Survival in Nonmetastatic Hepatocellular Carcinoma Patients
Justin Y Tang, Nitin Ohri, Rafi Kabarriti, et al.
Journal of Gastrointestinal Oncology
|
June 12, 2019
Centers with more therapeutic modalities are associated with improved outcomes for patients with hepatocellular carcinoma
Julie M Jiang, Nitin Ohri, Justin Tang, et al.
Clinical Colorectal Cancer
|
January 31, 2012
PTEN gene expression and mutations in the PIK3CA gene as predictors of clinical benefit to anti-epidermal growth factor receptor antibody therapy in patients with KRAS wild-type metastatic colorectal cancer
Arjun Sood, Danielle McClain, Radhashree Maitra, et al.
American Journal of Clinical Oncology
|
September 10, 2009
Phase II study of paclitaxel plus the protein kinase C inhibitor bryostatin-1 in advanced pancreatic carcinoma
Anthony P Lam, Joseph A Sparano, Vincent Vinciguerra, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
October 12, 2022
Induction Chemotherapy With FOLFIRINOX Followed by Chemoradiation With Gemcitabine in Patients With Borderline-Resectable Pancreatic Ductal Adenocarcinoma
Ana Acuna-Villaorduna, Viswanathan Shankar, Michael Wysota, et al.
Investigational New Drugs
|
January 2, 2007
Pharmacokinetic and safety study of weekly irinotecan and oral capecitabine in patients with advanced solid cancers
Sanjay Goel, Kavita Desai, Sirisha Karri, et al.
Investigational New Drugs
|
October 14, 2018
Survival outcome and prognostic model of patients with colorectal cancer on phase 1 trials
Audrey E Kam, Gopichand Pendurti, Umang H Shah, et al.
Page
of 4